Skip to main content

Advertisement

SpringerLink
Log in

Growth Factor Network Disruption in Prostate Cancer Progression

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Prostate cancer progression is often accompanied by alterations of expression in one or more growth factor receptors and/or their ligands. This commentary examines the hypothesis that the disruption of the normal growth factor network itself is a critical event in prostate cancer progression. If such transition points are proven, there are significant ramifications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Maygarden SJ, Novotny DB, Moul JL, Bae VL, Ware JL: Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod Pathol 7: 930-936, 1994

    PubMed  Google Scholar 

  2. Scher HI, Sarbis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Funks Z, Mendelson J, Cordon-Cardo C: Changing pattern of expression of the epidemal growth factor receptor and transforming growth alpha in the progression prostatic of neoplasms. Clin Cancer Res 1: 545-550, 1995

    PubMed  Google Scholar 

  3. Freeman MR, Paul S, Haefer M, Ishibawa M, Adam RM, Renshaw AA, Elenius K, Klagsbrun M: Heparin-binding EGF-like growth factor in the human prostate: Synthesis predominately by intestinal and vascular smooth muscle cells and action as a carcinoma cell mitogen. J Cell Biochem 68: 328-338, 1998

    Article  PubMed  Google Scholar 

  4. Cohen P, Peehl DM, Lamson G, Rosenfield RG: Insulin-like growth factors (IGF), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. Clin Endoc Metab 73: 401-407, 1991

    Google Scholar 

  5. Longo A, Gianni S, Natali A, Costanini A, Vannello GB, Serio M: Insulin-like growth factor-1 receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulators by chronic treatment gonadotrophin-releasing analog. J Clin Endocrinol Metab 72: 240-246, 1991

    Google Scholar 

  6. Tennant M, Thrasher J, Twomey P, Drivdahl R, Birnbaum R, Plymate S: Protein and messenger ribonucleic (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrin Metab 81: 3774-3782, 1996

    Article  Google Scholar 

  7. Tennant M, Thrasher JB, Twomey PA, Bimbaum R, Plymate S: Insulin-like growth factor binding proteins (IGFBP)-4,-5,-6 in the benign and malignant human prostate: IGFBPS messenger ribonucleic acid localization differs fromIGFBP-5 protein localization. J Clin Endocrinol Metab 81: 3783-3792, 1996

    Article  PubMed  Google Scholar 

  8. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton N, Sultan C: Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in culture. J Clin Endocrinol Metab 81: 612-617, 1996

    Article  PubMed  Google Scholar 

  9. Plymate S, Hwa V, Thomasini C, Maddison L, Thrasher JB, Swisshelm K, Rosenfeld RG: Insulin-like growth factor binding protein 7 expression and regulation in the human prostate. Prog Endocrine Soc 1997, p 351 (abstract)

  10. Ware JL, Strom SC, Maygarden SJ: Immunohistochemical evidence for expression of the c-erb B-2 protein in human prostatic carcinoma. Hum Pathol 22: 254-258, 1991

    Article  PubMed  Google Scholar 

  11. Kuhn EJ, Kurnot RA, Sesterhenn IA, Chang EH, Moul JW: Expression of the c-erb B2 (HER-2/neu) oncoprotein in human prostatic carcinoma. J Urol 150: 1427-1433, 1993

    PubMed  Google Scholar 

  12. Yan G, Fukabori Y, Nikolaropuolos S, Wang F, McKeehan WL: Heparin-binding keritinocyte growth factor is a candidate stromal-to-epithelial andromedin. Mol Endocrinol 6: 2123-8, 1992

    Article  PubMed  Google Scholar 

  13. Ropiquet F, Berthon P, Villette JM, LeBrun G, Maitland NJ, Cussenot O, Fiet J: Constitutive expression of FGF2/bFGF in non-tumorgenetic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype. Int J Cancer 72: 543-7, 1997

    Article  PubMed  Google Scholar 

  14. Kim IY, Ahn HJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazara K, Nemeth JA, Kozlowski JM, Lee C: Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 2: 1255-1261, 1996

    PubMed  Google Scholar 

  15. Guo Y, Kyprianov N: Overexpression of transforming growth factor (TGF) beta type II receptor restores TGF beta sensitivity and signaling in human prostate cancer cells. Cell Growth Differ 9: 185-93, 1998

    PubMed  Google Scholar 

  16. Peusner L: Studies in Network Thermodynamics. Elsevier Publishing, Amsterdam, 1986

    Google Scholar 

  17. Mikalecky DC: A comparison between the formal description of reaction and neural networks: A network thermodynamic approach. In: Mikalecky DC, Clarke AM (ed) Biomedical Engineering: Opening New Doors, New York University Press, New York, 1990, pp 67-74

    Google Scholar 

  18. Hopfield JJ, Tanks DW: Computing with neural circuits: a model. Science 233: 625-633, 1986

    PubMed  Google Scholar 

  19. Elson SD, Browne CA, Thorburn GG: Identification of epidermal growth factor-like activity in human male reproductive tissue and fluids. J Clin Endocrinol Metab 48: 673-679, 1984

    Google Scholar 

  20. Moul JW, Maygarden SJ, Ware JL, Mohler JL, Maher PD, Schenkman NS, Ho CK: Cathepsin D and epidermal growth factor receptors (EGFR) immunohistochemistry does not predict outcome of prostate cancer patients undergoing radical prostatetectomy. J Urol 155: 982-985, 1996

    Article  PubMed  Google Scholar 

  21. Robinson D, Feng H, Pretlow T, Kung HJ: A tyrosine kinase profile of a prostate carcinoma. Proc Nat Acad Sci USA 93: 5958-5962, 1996

    Article  PubMed  Google Scholar 

  22. Fong CJ, Sherwood ER, Mendleson J, Lee C, Kozlowski JM: Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitized androgen-independent prostatic carcinoma cells to tumor neurosis factor α. Cancer Res 52: 5887-5892, 1992

    PubMed  Google Scholar 

  23. Ching KZ, Ramsay CE, Pethgrew N, Cunha RH, Jason M, Dodd JG: Expression of mRNA for epidermal growth factor, transforming growth factor alpha, and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126: 151-158, 1993

    PubMed  Google Scholar 

  24. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL: Tumorigeniaty of SV40T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58: 721-729, 1994

    PubMed  Google Scholar 

  25. Angellon-Nicoud P, Benoux M: Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IFG-binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinol 136: 5485-5492, 1995

    Article  Google Scholar 

  26. Pietizkowski Z, Mulholland G, Gomella L, Jameson B, Wermicle D, Baserga R: Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res 53: 1102-1106, 1993

    PubMed  Google Scholar 

  27. Jackson-Cook C, Bae V, Edelman W, Brothman A, Ware J: Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorgenic sublines M2182 and M15. Cancer Genet Cytogenet 87: 14-23, 1996

    Article  PubMed  Google Scholar 

  28. Bae VL, Jackson-Cook CK, Maygarden SJ, Plymate S, Chen J, Ware JL: Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate 34: 275-282, 1998

    Article  PubMed  Google Scholar 

  29. Watson BW, Ware JL, Ferreira-Gonzalez A, Wilkinson DS, Garrett CT: Identification of subchromosomal regions associated with phenotypic changes in a human prostate cancer model using microsatellite loss of heterozygosity (LOH) analysis. Proc Am Assoc Cancer Res 39: 342 (Abstract 2 339), 1998

    Google Scholar 

  30. Plymate SR, Bae VL, Maddison L, Quinn LS, Ware JL: Re-expression of the type 1 IGF receptor (IGF-IR) inhibits the malignant phenotype of SV40 T-immortalized human prostate epithelial cells. Endocrinol 138: 1728-1735, 1997

    Article  Google Scholar 

  31. Damon SE, Maddison L, Ware JL and Plymate SR: Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostatic tumor formation. Endocrinol 139: 3456-3464, 1998

    Article  Google Scholar 

  32. Webber MM, Bello D, Quader S: Immortalized and tumorgenic adult human prostatic epithelial cell lines: characteristics and applications. Part 2. Tumorgenic cell lines. Prostate 30: 58-64, 1997

    PubMed  Google Scholar 

  33. Niederberger C: Computational tools for the modern andrologist. J Androl 17: 462-466, 1996

    PubMed  Google Scholar 

  34. Prideaux JA, Mikulecky DC, Clarke AM, Ware JL: A modified neural network model of tumor cell interactions and sub-population dynamics. Invasion Metastasis 13: 50-56, 1993

    PubMed  Google Scholar 

  35. Miles BJ, Katlan MW: Computer modeling of prostate cancer treatment. A paradigm for oncologic management. Surg Oncol Clin N Am 4: 361-372, 1995

    PubMed  Google Scholar 

  36. Tewan A, Narayan P: Novel staging for localized prostate cancer: a pilot study using genetic adaptive neural networks. J Urol 160: 430-436, 1998

    PubMed  Google Scholar 

  37. Douglas TH, Moul JW: Applications of neural networks in urologic oncology. Semin Urol Oncol 16: 35-39, 1998

    PubMed  Google Scholar 

  38. Vawer A, Rashbass J: The biological toolbox: a computer program for simulating basic biological and pathological processes. Comput Meth Programs Biomed 52: 203-211, 1997

    Article  Google Scholar 

  39. Haas GP, Sakr W: Epidemiology of prostate cancer. CA 47: 273-287, 1997

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, VA, USA

    Joy L. Ware

Authors
  1. Joy L. Ware
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ware, J.L. Growth Factor Network Disruption in Prostate Cancer Progression. Cancer Metastasis Rev 17, 443–447 (1998). https://doi.org/10.1023/A:1006114527274

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006114527274

Search

Navigation